• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾素-血管紧张素系统符合癌症的特征。

The renin-angiotensin system meets the hallmarks of cancer.

作者信息

Wegman-Ostrosky Talia, Soto-Reyes Ernesto, Vidal-Millán Silvia, Sánchez-Corona José

机构信息

Instituto Nacional de Cancerología, División de Investigación, México Universidad de Guadalajara, Instituto de Génetica Humana, México.

Instituto Nacional de Cancerología, División de Investigación, México.

出版信息

J Renin Angiotensin Aldosterone Syst. 2015 Jun;16(2):227-33. doi: 10.1177/1470320313496858. Epub 2013 Aug 9.

DOI:10.1177/1470320313496858
PMID:23934336
Abstract

The hallmarks of cancer are described as the distinctive and complementary capacities that cells must acquire during the multistep development of becoming a cancer cell that allow them to survive, proliferate and disseminate. The renin-angiotensin system (RAS) was first discovered and extensively studied in the physiological regulation of systemic arterial pressure. RAS signalling increases cell proliferation in malignancy by directly affecting tumour and stromal cells and by indirectly modulating the growth of vascular cells during angiogenesis. We aim to describe and give a general view of how the RAS is involved in several hallmarks of cancer and how this could open a window to several interesting treatments.

摘要

癌症的特征被描述为细胞在成为癌细胞的多步骤发展过程中必须获得的独特且互补的能力,这些能力使它们能够存活、增殖和扩散。肾素-血管紧张素系统(RAS)最初是在全身动脉压的生理调节中被发现并广泛研究的。RAS信号传导通过直接影响肿瘤细胞和基质细胞以及在血管生成过程中间接调节血管细胞的生长,从而增加恶性肿瘤中的细胞增殖。我们旨在描述并概述RAS如何参与癌症的多个特征,以及这如何为一些有趣的治疗方法打开一扇窗。

相似文献

1
The renin-angiotensin system meets the hallmarks of cancer.肾素-血管紧张素系统符合癌症的特征。
J Renin Angiotensin Aldosterone Syst. 2015 Jun;16(2):227-33. doi: 10.1177/1470320313496858. Epub 2013 Aug 9.
2
The renin-angiotensin system and malignancy.肾素-血管紧张素系统与恶性肿瘤。
Carcinogenesis. 2008 Sep;29(9):1675-84. doi: 10.1093/carcin/bgn171. Epub 2008 Jul 16.
3
Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.肾素-血管紧张素系统对心力衰竭中心脏能量代谢的影响。
J Mol Cell Cardiol. 2013 Oct;63:98-106. doi: 10.1016/j.yjmcc.2013.07.010. Epub 2013 Jul 22.
4
[Cancer and renin-angiotensin system].[癌症与肾素-血管紧张素系统]
Nihon Rinsho. 2012 Sep;70(9):1530-5.
5
Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation.人类T细胞和自然杀伤细胞拥有功能性肾素-血管紧张素系统:血管紧张素II诱导炎症的进一步机制。
J Am Soc Nephrol. 2007 Apr;18(4):1093-102. doi: 10.1681/ASN.2006070707. Epub 2007 Feb 28.
6
Chemotherapy and radiation regimens to breast cancer treatment induce changes in mRNA levels of renin-angiotensin system related genes in cardiac tissue.化疗和放疗方案治疗乳腺癌会导致心脏组织中肾素-血管紧张素系统相关基因的 mRNA 水平发生变化。
J Renin Angiotensin Aldosterone Syst. 2013 Dec;14(4):330-6. doi: 10.1177/1470320312465218. Epub 2012 Nov 6.
7
Localisation of renin-angiotensin system (RAS) components in breast.肾素-血管紧张素系统(RAS)成分在乳腺中的定位。
Br J Cancer. 2006 Jul 3;95(1):67-74. doi: 10.1038/sj.bjc.6603213. Epub 2006 Jun 6.
8
The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms.脂肪组织肾素-血管紧张素系统与代谢紊乱:分子机制综述。
Crit Rev Biochem Mol Biol. 2012 Jul-Aug;47(4):379-90. doi: 10.3109/10409238.2012.694843.
9
The intracellular renin-angiotensin system: a new paradigm.细胞内肾素-血管紧张素系统:一种新范式。
Trends Endocrinol Metab. 2007 Jul;18(5):208-14. doi: 10.1016/j.tem.2007.05.001. Epub 2007 May 16.
10
Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis.原始、确定和肿瘤性造血中的局部骨髓肾素-血管紧张素系统。
Clin Sci (Lond). 2013 Mar;124(5):307-23. doi: 10.1042/CS20120300.

引用本文的文献

1
The role of angiotensinogen, angiotensin II receptor type I and type II receptor polymorphisms (AGTR2 rs11091046, AGT rs699, AGTR1 rs5186, and AGT rs4762) in multiple myeloma.血管紧张素原、血管紧张素 II 1型和2型受体多态性(AGTR2 rs11091046、AGT rs699、AGTR1 rs5186和AGT rs4762)在多发性骨髓瘤中的作用。
Discov Oncol. 2025 Aug 21;16(1):1588. doi: 10.1007/s12672-025-03443-w.
2
Role of Renin-Angiotensin System and Macrophages in Breast Cancer Microenvironment.肾素-血管紧张素系统与巨噬细胞在乳腺癌微环境中的作用
Diseases. 2025 Jul 10;13(7):216. doi: 10.3390/diseases13070216.
3
Thiosemicarbazide Derivative of Captopril (8) imposes Cellular-Dependent Death Modalities on Breast Cancer Cell Lines.
卡托普利的氨基硫脲衍生物(8)对乳腺癌细胞系施加细胞依赖性死亡模式。
Asian Pac J Cancer Prev. 2025 Jun 1;26(6):2061-2070. doi: 10.31557/APJCP.2025.26.6.2061.
4
Effects of agents acting on the renin-angiotensin system on the incidence of gastric cancer: A two-sample Mendelian randomization study.作用于肾素-血管紧张素系统的药物对胃癌发病率的影响:一项两样本孟德尔随机化研究
Medicine (Baltimore). 2025 Apr 25;104(17):e42017. doi: 10.1097/MD.0000000000042017.
5
Mediated roles of oxidative stress and kidney function to leukocyte telomere length and prognosis in chronic kidney disease.氧化应激和肾功能对慢性肾脏病患者白细胞端粒长度及预后的介导作用
Ren Fail. 2025 Dec;47(1):2464828. doi: 10.1080/0886022X.2025.2464828. Epub 2025 Feb 26.
6
Cancer Stem Cells and the Renin-Angiotensin System in the Tumor Microenvironment of Melanoma: Implications on Current Therapies.黑色素瘤肿瘤微环境中的癌症干细胞与肾素-血管紧张素系统:对当前治疗的启示
Int J Mol Sci. 2025 Feb 6;26(3):1389. doi: 10.3390/ijms26031389.
7
Correlation Between Antihypertensive Drugs and Survival Among Patients with Pancreatic Ductal Adenocarcinoma.降压药物与胰腺导管腺癌患者生存率之间的相关性
Cancers (Basel). 2024 Nov 25;16(23):3945. doi: 10.3390/cancers16233945.
8
Upregulation of the Renin-Angiotensin System Is Associated with Patient Survival and the Tumour Microenvironment in Glioblastoma.肾素-血管紧张素系统的上调与胶质母细胞瘤患者的生存和肿瘤微环境相关。
Cells. 2024 Apr 5;13(7):634. doi: 10.3390/cells13070634.
9
Genetic Variations Related to Angiotensin II Production and Risk for Basal Cell Carcinoma.与血管紧张素II生成及基底细胞癌风险相关的基因变异
Biochem Genet. 2025 Apr;63(2):917-935. doi: 10.1007/s10528-024-10746-0. Epub 2024 Mar 28.
10
Antihypertensive drug targets and breast cancer risk: a two-sample Mendelian randomization study.抗高血压药物靶点与乳腺癌风险:两样本孟德尔随机化研究。
Eur J Epidemiol. 2024 May;39(5):535-548. doi: 10.1007/s10654-024-01103-x. Epub 2024 Feb 24.